Alternatives to blood transfusion in transfusion medicine [[electronic resource] /] / edited by Alice Maniatis, Philippe van der Linden, Jean-François Hardy |
Edizione | [2nd ed.] |
Pubbl/distr/stampa | Chichester, West Sussex ; ; Hoboken, NJ, : John Wiley, 2010 |
Descrizione fisica | 1 online resource (608 p.) |
Disciplina | 615/.39 |
Altri autori (Persone) |
ManiatisAlice
LindenPhilippe van der HardyJean-François |
Soggetto topico |
Blood - Transfusion
Blood - Transfusion - Complications Blood substitutes - Therapeutic use |
ISBN |
1-4443-4766-7
1-282-77452-2 9786612774522 1-4443-1958-2 1-4443-1653-2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Alternatives to Blood Transfusion in Transfusion Medicine; Contents; Contributors List; Part 1 History and Development of Transfusion Medicine; 1 From Blood Transfusion to Transfusion Medicine; Part 2 Allogeneic Blood Usage-Risks and Benefits; 2 Allogeneic Blood Components; 3 Current Information on the Infectious Risks of Allogeneic Blood Transfusion; 4 Immunological Complications of Blood Transfusion; 5 Immunomodulation and Allogeneic Blood Transfusion; 6 Pathogen Inactivation of Blood Components; 7 The Benefits of Allogeneic Erythrocyte Transfusion: What Evidence Do We Have?
Part 3 Volume Replacement Section 1 Plasma and Albumin; Section 2 Crystalloids and Synthetic Colloids; Part 4 Tolerance of Anemia; 17 Basic Principles of Oxygen Transport and Calculations; 18 Assessment of Tissue Oxygenation; 19 Tissue Oxygenation and Blood Transfusion; 20 Anemia and Cardiovascular Disease; Part 5 Perioperative Hemostasis; 21 Monitoring of Hemostasis in the Perioperative Setting; 22 Antifibrinolytics in Open-Heart Surgery; 23 Efficacy and Safety of Recombinant Activated Factor VII to Control Bleeding in Nonhemophiliac Patients; Part 6 Transfusion Triggers 24 Role of Hemoglobin/Hematocrit 25 Calculation of Blood Loss; 26 Management of Massive Transfusion; Part 7 Alternatives to Allogeneic Blood Transfusion; Section 1 Pharmaceutical Approaches; Section 2 Surgical Techniques; Section 3 Anesthetic Techniques; Section 4 Special Settings; Part 8 Legal and Ethical Issues in Transfusion Medicine; 43 Ethical Aspects of Informed Consent: American Models; 44 Blood Transfusions, Jehovah's Witnesses, and the American Patients' Rights Movement; Part 9 Cost Issues; 45 The Cost and Cost-Effectiveness of Allogeneic and Autologous Blood 46 Autologous Blood Predonation in Cardiac Surgery 47 Cost-Effectiveness of Pharmacological Alternatives; Index |
Record Nr. | UNINA-9910140803903321 |
Chichester, West Sussex ; ; Hoboken, NJ, : John Wiley, 2010 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Alternatives to blood transfusion in transfusion medicine / / edited by Alice Maniatis, Philippe van der Linden, Jean-François Hardy |
Edizione | [2nd ed.] |
Pubbl/distr/stampa | Chichester, West Sussex ; ; Hoboken, NJ, : John Wiley, 2010 |
Descrizione fisica | 1 online resource (608 p.) |
Disciplina | 615/.39 |
Altri autori (Persone) |
ManiatisAlice
LindenPhilippe van der HardyJean-François |
Soggetto topico |
Blood - Transfusion
Blood - Transfusion - Complications Blood substitutes - Therapeutic use |
ISBN |
1-4443-4766-7
1-282-77452-2 9786612774522 1-4443-1958-2 1-4443-1653-2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Alternatives to Blood Transfusion in Transfusion Medicine; Contents; Contributors List; Part 1 History and Development of Transfusion Medicine; 1 From Blood Transfusion to Transfusion Medicine; Part 2 Allogeneic Blood Usage-Risks and Benefits; 2 Allogeneic Blood Components; 3 Current Information on the Infectious Risks of Allogeneic Blood Transfusion; 4 Immunological Complications of Blood Transfusion; 5 Immunomodulation and Allogeneic Blood Transfusion; 6 Pathogen Inactivation of Blood Components; 7 The Benefits of Allogeneic Erythrocyte Transfusion: What Evidence Do We Have?
Part 3 Volume Replacement Section 1 Plasma and Albumin; Section 2 Crystalloids and Synthetic Colloids; Part 4 Tolerance of Anemia; 17 Basic Principles of Oxygen Transport and Calculations; 18 Assessment of Tissue Oxygenation; 19 Tissue Oxygenation and Blood Transfusion; 20 Anemia and Cardiovascular Disease; Part 5 Perioperative Hemostasis; 21 Monitoring of Hemostasis in the Perioperative Setting; 22 Antifibrinolytics in Open-Heart Surgery; 23 Efficacy and Safety of Recombinant Activated Factor VII to Control Bleeding in Nonhemophiliac Patients; Part 6 Transfusion Triggers 24 Role of Hemoglobin/Hematocrit 25 Calculation of Blood Loss; 26 Management of Massive Transfusion; Part 7 Alternatives to Allogeneic Blood Transfusion; Section 1 Pharmaceutical Approaches; Section 2 Surgical Techniques; Section 3 Anesthetic Techniques; Section 4 Special Settings; Part 8 Legal and Ethical Issues in Transfusion Medicine; 43 Ethical Aspects of Informed Consent: American Models; 44 Blood Transfusions, Jehovah's Witnesses, and the American Patients' Rights Movement; Part 9 Cost Issues; 45 The Cost and Cost-Effectiveness of Allogeneic and Autologous Blood 46 Autologous Blood Predonation in Cardiac Surgery 47 Cost-Effectiveness of Pharmacological Alternatives; Index |
Record Nr. | UNINA-9910810936103321 |
Chichester, West Sussex ; ; Hoboken, NJ, : John Wiley, 2010 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|